截至9:36,港股创新药ETF(513120)涨0.93%,成分股中,三叶草生物-B涨超8%,绿叶制药涨超4.5%,开拓药业-B、云顶新耀-B等涨超4%。同一时间,创新药ETF(515120)涨0.27%,成分股中,康希诺涨超3.5%。医药卫生ETF(159938)涨0.85%,成分股中,尚荣医疗、太龙药业涨停。
浙商证券认为,依托国内/外需求起步的医药CXO,必然在国内仿创升级生态优化的过程中充当越来越重要的角色,迎来越来越好的发展窗口。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.